HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate FDA reform hearing on Feb. 21 includes ex-FDAers; Sen. Mack to lead-off on Feb. 22.

This article was originally published in The Rose Sheet

Executive Summary

SENATE FDA REFORM HEARING WILL FEATURE PANEL OF EX-FDA MANAGERS including former Center for Drug Evaluation & Research Director Carl Peck, MD; former Center for Devices & Radiologic Health Director John Villforth; former Center for Veterinary Medicine Director Lester Crawford, PhD; and former Deputy Commissioner Sherwin Gardner. The four will testify Feb. 21 before Sen. Nancy Kassebaum's (R-KS) Labor & Human Resources Committee.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002521

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel